Invitris
YC W23Munich, DE · Founded 2022 · 6 employees · 1 known investors
Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.
Founders & leadership· Y Combinator alumni (W23)
Patrick GrossmanninFounder
Kilian VogeleinFounder